chartexchange

Electra Therapeutics Reports Third Quarter 2026 Financial Results and Recent Portfolio Highlights

GlobeNewswire Inc. | Nov 12, 2026 4:01 PM EST

Ipsoprubart Advancing in Global Registrational Program as Potential First Treatment for sHLH Broadly; Enrollment Completion Expected in Second Half of 2027

Read original article